Colorectal cancer is the third most common cancer in Iowa and the second leading cause of death from cancer, according to the State Health Registry of Iowa. However, the good news is that a simple screening and early detection can help Iowans survive colon cancer and help prevent this deadly disease.
University of Iowa spin-off Viewpoint Molecular Targeting has recently been awarded a $2 million Phase II NIH SBIR to support development of a new treatment for metastatic melanoma.
Holden Comprehensive Cancer Center researcher Yousef Zakharia, MD, has presented promising data at a national meeting about combining a new investigational immunotherapy drug with an FDA-approved immunotherapy drug to treat patients with advanced melanoma.
Evidence is growing that adding high-dose, intravenous vitamin C in combination with standard chemotherapy and radiation treatment is a safe, relatively inexpensive approach that may improve outcomes for patients with a wide range of cancers.
Like most of us, when biologist Laura Rogers, PhD, hears stories about immunotherapy and the new hope it’s bringing to cancer patients, the word “miraculous” comes to her mind.
At the time, it wasn't his heart that was causing some problems. More specifically, Jerry developed a sudden onset of complete heart block - when the heart's own electricity stops moving through the ventricles, according to Lenni O'Neill Broeg, BSN, RN, an electrophysiology nurse in the University of Iowa Heart and Vascular Center. A week later, after his heart started showing signs of strengthening, a cardiac resynchronization pacemaker – or CRT-P – was implanted.
During her third trimester, Kelli Carlson was not feeling well. Her physician told her that her symptoms were a normal part of pregnancy, but it turned out they were actually signs of preeclampsia–a high blood pressure disorder in pregnancy.
The UI Heart and Vascular Center has a history of excellence in minimally invasive procedures and that tradition continues with the transcatheter aortic valve replacement (TAVR) procedure. TAVR is a treatment for aortic stenosis – the narrowing of the aortic valve causing an obstruction of blood flow to the heart. The UI Heart and Vascular Center performed its 500th TAVR procedure in January.
